Side-by-side comparison of mechanisms, dosing, interactions, and stacking potential.
| Armodafinil | L-Theanine | |
|---|---|---|
| Category | Nootropics | Amino Acids |
| Standard Dose | 75-150 mg once daily (for educational context only — prescription medication in most jurisdictions) | 100-200mg daily (or as needed for acute anxiety/focus) |
| Timing | Early morning. 150 mg armodafinil provides comparable late-day wakefulness to 200 mg modafinil. Food delays Tmax by ~2-4 hours but does not affect total absorption. Half-life approximately 15-16.5 hours. | Flexible: morning for calm focus (stack with caffeine), before stressful events, or evening for relaxation/sleep onset. Onset: 30-60 minutes oral, 15-20 min sublingual. |
| Cycle Duration | Same as modafinil; not typically cycled in clinical use. | ongoing or as needed |
| Evidence Level | strong_human | strong_human |
The isolated R-enantiomer of racemic modafinil, sharing the same primary mechanism — selective inhibition of the dopamine transporter (DAT) — but with distinct pharmacokinetics. The R-enantiomer has a terminal half-life of ~15 hours vs. ~4-5 hours for the S-enantiomer, resulting in 33-40% higher plasma AUC compared to equimolar racemic modafinil. This translates to more sustained wakefulness-promoting activity throughout the day. Same downstream activation of orexinergic, histaminergic, and noradrenergic pathways as modafinil.
75-150 mg once daily (for educational context only — prescription medication in most jurisdictions)
Early morning. 150 mg armodafinil provides comparable late-day wakefulness to 200 mg modafinil. Food delays Tmax by ~2-4 hours but does not affect total absorption. Half-life approximately 15-16.5 hours.
Same as modafinil; not typically cycled in clinical use.
L-Theanine (gamma-glutamylethylamide) crosses the blood-brain barrier via the large neutral amino acid transporter. It increases alpha brain wave activity (8-13 Hz, associated with relaxed alertness), enhances GABA, serotonin, and dopamine levels in the brain, and antagonizes glutamate excitotoxicity by blocking glutamate binding at AMPA, kainate, and NMDA receptors. It also increases BDNF and NGF expression, supporting neuroplasticity. The combination of glutamate antagonism and GABA/serotonin enhancement produces anxiolysis without sedation — a 'calm focus' state.
100-200mg daily (or as needed for acute anxiety/focus)
Flexible: morning for calm focus (stack with caffeine), before stressful events, or evening for relaxation/sleep onset. Onset: 30-60 minutes oral, 15-20 min sublingual.
ongoing or as needed
Take our free assessment to get personalized recommendations based on your health goals, current stack, and biomarkers.
Get Your Free Protocol →or take the assessment →